These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [A clinical significance of oral ursodeoxycholic acid tolerance test for patients with hepatobiliary diseases by using radioimmunoassay (author's transl)]. Shinozaki K Rinsho Byori; 1981 May; 29(5):475-7. PubMed ID: 7289113 [No Abstract] [Full Text] [Related]
4. 125I Radioimmunoassay of serum ursodeoxycholyl conjugates. Hill A; Ross PE; Bouchier IA Clin Chim Acta; 1983 Feb; 127(3):327-36. PubMed ID: 6839487 [TBL] [Abstract][Full Text] [Related]
5. [The treatment of dyspeptic disturbances with ursodesoxycholic acid (author's transl)]. Töndury GD Schweiz Rundsch Med Prax; 1981 May; 70(21):969-73. PubMed ID: 7243733 [No Abstract] [Full Text] [Related]
7. Radioimmunoassay of ursodeoxycholic acid in serum. Makino I; Tashiro A; Hashimoto H; Nakagawa S; Yoshizawa I J Lipid Res; 1978 May; 19(4):443-7. PubMed ID: 659985 [TBL] [Abstract][Full Text] [Related]
8. [Change of serum bile acids levels after administration of UDCA and test meals (author's transl)]. Inaguma H Nihon Shokakibyo Gakkai Zasshi; 1982 Feb; 79(2):289. PubMed ID: 7098117 [No Abstract] [Full Text] [Related]
9. [Direct conversion of ursodeoxycholic acid to chenodeoxycholic acid by human intestinal microorganisms under the anaerobic condition (author's transl)]. Higashi S; Setoguchi T; Katsuki T Nihon Shokakibyo Gakkai Zasshi; 1980 Jan; 77(1):113. PubMed ID: 7359762 [No Abstract] [Full Text] [Related]
10. [A comparative study of serum bile acid levels (TBA, CG) in liver disease-difference between fasting and UDCA oral loading (author's transl)]. Hino K; Yamamoto S; Yamashita S; Fukushima K; Ohashi K Nihon Shokakibyo Gakkai Zasshi; 1981 Nov; 78(11):2197. PubMed ID: 7328844 [No Abstract] [Full Text] [Related]
11. Effect of ursodeoxycholic acid on liver structure in man. Quantitative data. Koch MM; Giampieri MP; Lorenzini I; Jézéquel AM; Orlandi F Gastroenterol Clin Biol; 1980; 4(8-9):560-8. PubMed ID: 7429103 [No Abstract] [Full Text] [Related]
12. [Diagnostic value of oral bile acid tolerance test (author's transl)]. Matsumoto H; Masamune O; Nunode Y; Ohshiba S Nihon Shokakibyo Gakkai Zasshi; 1981 Jul; 78(7):1380-7. PubMed ID: 7311082 [No Abstract] [Full Text] [Related]
13. Ursodeoxycholic acid and liver microsomal mixed function oxidase system in man. Di Padova C; Tritapepe R; Marabini L; Di Padova F; Rovagnati P; Mazzocchi M Methods Find Exp Clin Pharmacol; 1981; 3(4):209-11. PubMed ID: 7278432 [No Abstract] [Full Text] [Related]
14. [Pharmacokinetics and hepatic metabolism of ursulcholic acid (a soluble form of ursodeoxycholic acid in the rat]. Franzone JS; Santiano M; Reboani C; Grigolo B; Simoni P Boll Chim Farm; 1987 Jul; 126(7):289-93. PubMed ID: 3452329 [No Abstract] [Full Text] [Related]
15. Cholesterol absorption during bile acid feeding. Effect of ursodeoxycholic acid (UDCA) administration. Ponz de Leon M; Carulli N; Loria P; Iori R; Zironi F Gastroenterology; 1980 Feb; 78(2):214-9. PubMed ID: 7350042 [No Abstract] [Full Text] [Related]
16. [Further progress in the pharmacological dissolution of biliary calculi with ursodeoxycholic acid]. Bojanowicz K; Witkowska A Wiad Lek; 1981 Aug; 34(16):1363-7. PubMed ID: 7340149 [No Abstract] [Full Text] [Related]
18. [Undesirable effects of chenodeoxycholic acid and ursodeoxycholic acid: what the goose and the bear don't have in common]. Capron JP Gastroenterol Clin Biol; 1980; 4(8-9):526-30. PubMed ID: 7429098 [No Abstract] [Full Text] [Related]
19. Stability of ursodeoxycholic acid 7-oleyl ester to enzymatic hydrolysis. Marzo A; Treffner E; Sansó G; Rapelli S Boll Chim Farm; 1985 Mar; 124(3):150-2. PubMed ID: 4027025 [No Abstract] [Full Text] [Related]
20. Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans. Salen G; Colalillo A; Verga D; Bagan E; Tint GS; Shefer S Gastroenterology; 1980 Jun; 78(6):1412-8. PubMed ID: 7372061 [No Abstract] [Full Text] [Related] [Next] [New Search]